As of June 2024 Spyre Therapeutics has a market cap of $1.13 Billion. This makes Spyre Therapeutics the world's 4979th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.13 B | 46.12% |
2023 | $0.77 B | 2701.1% |
2022 | $27.67 M | -88.2% |
2021 | $0.23 B | -37.89% |
2020 | $0.37 B | 69.86% |
2019 | $0.22 B | 22.89% |
2018 | $0.18 B | 100.8% |
2017 | $90.04 M | 54.12% |
2016 | $58.42 M |
On Jun 25th, 2024 the market cap of Spyre Therapeutics was reported to be: